Biohaven (BHVN) Retained Earnings (2022 - 2026)
Biohaven (BHVN) posted Retained Earnings of -$2.2 billion for Q1 2026, down 1241.88% sequentially from $194.0 million in Q4 2025, and down 41.32% YoY from -$3.8 billion in Q1 2025.
Biohaven (BHVN) Retained Earnings (2022 - 2026) Analysis & Trends
Biohaven has reported Retained Earnings for 5 years, with the latest figure at -$2.2 billion in Q1 2026.
- Quarterly Retained Earnings fell 41.32% year-over-year to -$2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 billion (down 41.32% YoY) and the FY2025 annual result came in at $194.0 million, up 114.41% from the prior year.
- Retained Earnings slipped to -$2.2 billion in Q1 2026 per BHVN's latest filing, from $194.0 million in the prior quarter.
- Over five years, Retained Earnings peaked at $194.0 million in Q4 2025 and troughed at -$2.2 billion in Q1 2026.
- A 5-year average of -$520.4 million and a median of $101000.0 in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2023 and 2024: Retained Earnings slumped 175907.04% in 2023, then soared 41698.19% in 2024.
- Over 5 years, Retained Earnings stood at $284000.0 in 2022, then plunged by 175907.04% to -$499.3 million in 2023, then slumped by 169.52% to -$1.3 billion in 2024, then surged by 114.41% to $194.0 million in 2025, then slumped by 1241.88% to -$2.2 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$2.2 billion, $194.0 million, and $36000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - | -2.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.35 Bn |
| Mar 31, 2026 | -2.22 Bn |
| Dec 31, 2025 | 193.98 Mn |
| Sep 30, 2025 | 36,000.00 |
| Jun 30, 2025 | -1.77 Bn |
| Mar 31, 2025 | -1.57 Bn |
| Dec 31, 2024 | -1.35 Bn |
| Sep 30, 2024 | 93.04 Mn |
| Jun 30, 2024 | 83.83 Mn |
| Mar 31, 2024 | 69.39 Mn |
| Dec 31, 2023 | -499.29 Mn |
| Sep 30, 2023 | -354.54 Mn |
| Jun 30, 2023 | 21.69 Mn |
| Mar 31, 2023 | 166,000.00 |
| Dec 31, 2022 | 284,000.00 |